Norm-critical innovation as a way forward for responsible innovation? Evidence from a Swedish innovation policy program

Fuenfschilling, Lea; Paxling, Linda; Vico, Eugenia Perez

doi:10.1080/23299460.2022.2112817

Cited by 4 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Digital health, by necessity, brings together many stakeholder groups, sitting at the nexus of drug development, clinical practice, technology, software, and analytics [2] . As a new field, such collaboration is vitally important for “norm-critical innovation” [32] , as it facilitates exploration of solutions outside the experience of individual stakeholder groups. What may be novel to one group may be standard practice in another.…”

Section: Momentum In the Digital Measure Fieldmentioning

confidence: 99%

Reverse Engineering of Digital Measures: Inviting Patients to the Conversation

Clay,

Peerenboom,

Connors

et al. 2023

Digit Biomark

View full text Add to dashboard Cite

Background: Digital measures offer an unparalleled opportunity to create a more holistic picture of how people who are patients behave in their real-world environments, thereby establishing a better connection between patients, caregivers, and the clinical evidence used to drive drug development and disease management. Reaching this vision will require achieving a new level of co-creation between the stakeholders who design, develop, use, and make decisions using evidence from digital measures. Summary: In September 2022, the second in a series of meetings hosted by the Swiss Federal Institute of Technology in Zürich, the Foundation for the National Institutes of Health Biomarkers Consortium, and sponsored by Wellcome Trust, entitled “Reverse Engineering of Digital Measures,” was held in Zurich, Switzerland, with a broad range of stakeholders sharing their experience across four case studies to examine how patient centricity is essential in shaping development and validation of digital evidence generation tools. Key Messages: In this paper, we discuss progress and the remaining barriers to widespread use of digital measures for evidence generation in clinical development and care delivery. We also present key discussion points and takeaways in order to continue discourse and provide a basis for dissemination and outreach to the wider community and other stakeholders. The work presented here shows us a blueprint for how and why the patient voice can be thoughtfully integrated into digital measure development and that continued multistakeholder engagement is critical for further progress.

show abstract

Section: Momentum In the Digital Measure Fieldmentioning

confidence: 99%